Skip to main content

Table 2 Effect estimates for interventions with multiple studies reporting outcomes

From: The effectiveness of non-pharmacological sleep interventions for people with chronic pain: a systematic review and meta-analysis

Follow up

Effect measure

Number of studies (participants)

Effect estimate (95%CI), p-value

I2

Cognitive behavioural therapy for insomnia versus control

Sleep quality from questionnaire

 Post-treatment

SMD

9 (203:183)

-1.23 (−1.76, − 0.70), p < 0.00001

80%

 3 months

SMD

2 (65:68)

−0.80 (−2.17, 0.57), p = 0.25

93%

 6 months

SMD

3 (64:70)

−0.51 (−1.02, − 0.01), p = 0.04

41%

Sleep - onset latency (diary)

 Post-treatment

MD

7 (168:160)

−17.42 (−28.41, −6.43), p = 0.002

73%

 3 months

MD

2 (64:70)

−14.58 (−21.67, −7.50), < 0.0001

0%

 6 months

MD

3 (62:68)

−6.48 (−14.36, 1.40), p = 0.11

0%

Sleep - efficiency (diary)

 Post-treatment

MD

8 (174:164)

−9.86 (−14.06, −5.66), p = < 0.00001

67%

 3 months

MD

2 (64:70)

−9.36 (− 15.10, − 3.61), p = 0.001

53%

 6 months

MD

3 (62:68)

−6.16 (−10.31, −2.01), p = 0.004

46%

Sleep – wake after sleep onset (diary)

 Post-treatment

MD

7 (168:160)

−31.12 (−43.55, − 18.69), p < 0.00001

71%

 3 months

MD

2 (64:70)

−29.15 (−55.10, − 3.19), p = 0.03

67%

 6 months

MD

4 (85:96)

−18.58 (−30.57, −6.58), p = 0.002

51%

Sleep awakenings (diary)

 Post-treatment

MD

2 (51:37)

−0.23 (− 0.88, 0.42), p = 0.48

0%

Sleep - total sleep time (diary)

 Post-treatment

MD

8 (174:164)

−6.70 (−31.98, 18.58), p = 0.60

58%

 3 months

MD

2 (64:70)

−22.10 (−69.11, 24.91), p = 0.36

73%

 6 months

MD

4 (85:96)

−2.44 (− 22.15, 17.26), p = 0.81

0%

Sleep - onset latency (actigraph)

 Post-treatment

MD

3 (80:81)

−3.89 (−14.55, 6.77), p = 0.47

63%

 6 months

MD

3 (56:64)

−4.15 (−9.97, 1.68), p = 0.16

0%

Sleep - efficiency (actigraph)

 Post-treatment

MD

4 (96:96)

−1.58 (−5.59, 2.42), p = 0.44

50%

 6 months

MD

3 (55:65)

−2.17 (−5.42, 1.09), p = 0.19

0%

Sleep – wake after sleep onset (actigraph)

 Post-treatment

MD

3 (80:81)

−13.12 (− 24.39, − 1.85), p = 0.02

0%

 6 months

MD

3 (56:64)

−8.31 (−20.16, 3.53), p = 0.17

0%

Sleep - Total sleep time (actigraph)

 Post-treatment

MD

4 (96:96)

13.66 (−18.58, 45.91), p = 0.41

51%

 6 months

MD

3 (56:64)

17.50 (−9.93, 44.93), p = 0.21

11%

Sleep - onset latency (polysomnograph)

 Post-treatment

MD

2 (65:74)

5.89 (−9.16, 20.93), p = 0.44

0%

 6 months

MD

2 (56:59)

−5.24 (−23.33, 12.84), p = 0.57

0%

Sleep - efficiency (polysomnograph)

 Post-treatment

MD

2 (65:74)

−5.06 (−9.55, −0.57), p = 0.03

0%

 6 months

MD

2 (56:59)

−4.39 (−9.11, 0.33), p = 0.07

0%

Sleep – wake after sleep onset (polysomnograph)

 Post-treatment

MD

2 (65:74)

−33.91 (−51.82, −16.00), p = 0.0002

0%

 6 months

MD

2 (56:59)

−22.45 (−41.93, − 2.97), p = 0.02

0%

Sleep - Total sleep time (polysomnograph)

 Post-treatment

MD

2 (65:74)

16.41 (−23.60, 56.42), p = 0.42

29%

 6 months

MD

2 (56:59)

18.63 (−12.36, 49.62), p = 0.24

0%

Sleep - Epworth Sleepiness Scale

 Post-treatment

MD

2 (22:19)

−0.58 (−3.30, 2.14), p = 0.68

0%

Pain

 Post-treatment

SMD

9 (192:178)

−0.24 (− 0.45, − 0.03), p = 0.02

0%

 3 months

SMD

3 (83:83)

−0.31 (− 0.69, 0.07), p = 0.11

31%

 6 months

SMD

3 (66:70)

0.07 (−0.27, 0.41), p = 0.68

0%

Anxiety

 Post-treatment

SMD

3 (53:53)

−0.54 (−1.01, − 0.06), p = 0.03

28%

Depression

 Post-treatment

SMD

6 (123:113)

−0.57 (−1.05, − 0.08), p = 0.008

65%

 3 months

SMD

2 (48:43)

−0.37 (− 0.79, 0.05), p = 0.08

0%

Cognitive behavioural therapy for insomnia versus sleep hygiene

Sleep quality from questionnaire

 Post-treatment

SMD

3 (65:64)

−0.25 (− 0.82, 0.33), p = 0.40

61%

 6 months

SMD

2 (33:27)

−0.12 (− 0.84, 0.59), p = 0.73

34%

Pain

 Post-treatment

SMD

3 (65:64)

−0.51 (−1.17, 0.15), p = 0.13

70%

 6 months

SMD

2 (33:27)

0.54 (−1.30, 2.38), p = 0.57

85%

Health related quality of life

 Post-treatment

SMD

2 (50:47)

−0.79 (−1.20, − 0.37), p = 0.0002

0%

Anxiety

 Post-treatment

SMD

2 (50;47)

−0.32 (− 0.72, 0.08), p = 0.12

0%

Depression

 Post-treatment

SMD

2 (50;47)

−0.61 (−1.05, − 0.18), p = 0.006

11%

Cognitive behavioural therapy for insomnia and pain versus no treatment, wait list or attentional control

Sleep quality from questionnaire

 Post-treatment

SMD

4 (180:192)

−0.79 (−1.58, 0.00), p = 0.05

88%

 3 months

SMD

2 (56:56)

−0.41 (−1.96, 1.15), p = 0.61

94%

 6 months

SMD

2 (142:150)

−0.76 (−1.85, 0.33), p = 0.17

92%

Sleep - Total sleep time (diary)

 Post-treatment

MD

2 (40:34)

−61.58 (−105.25, − 17.91), p = 0.006

0%

Pain

 Post-treatment

SMD

4 (180:182)

−0.13 (−0.36, 0.10), p = 0.28

10%

 3 months

SMD

2 (56:56)

−0.48 (− 0.86, − 0.10), p = 0.01

0%

 6 months

SMD

3 (161:395)

−0.25 (− 0.62, 0.13), p = 0.20

58%

Health related quality of life

 Post-treatment

MD

2 (58:65)

−1.77 (−5.33, 1.78), p = 0.33

98%

 3 months

MD

2 (54:49)

−1.84 (−5.90, 2.22), p = 037

98%

Depression

 Post-treatment

SMD

2 (33:42)

0.14 (−0.54, 0.83), p = 0.68

33%

Cognitive behavioural therapy for insomnia and pain versus cognitive behavioural therapy for pain

Sleep quality from questionnaire

 Post-treatment

SMD

3 (146:150)

−0.47 (−1.19, 0.25), p = 0.20

75%

Pain

 Post-treatment only

SMD

3 (146:150)

−0.03 (− 0.26, 0.20), p = 0.78

0%

Heath related quality of life

 Post-treatment

SMD

2 (139;145)

0.03 (−0.20, 0.26), p = 0.81

0%

Depression

 Post-treatment

SMD

2 (33:33)

−0.34 (−1.05, 0.37), p = 0.35

28%

Mindfulness versus control

Sleep quality from questionnaire

 Post-treatment

SMD

2 (105:92)

−0.41 (−0.72, − 0.11), p = 0.008

14%

Pain

 Post-treatment

SMD

2 (105:92)

−0.35 (− 0.63, − 0.06), p = 0.02

0%

Health related quality of life

 Post-treatment

SMD

2 (105:92)

−0.28 (− 0.81, 0.26), p = 0.31

72%

Sleep hygiene versus standard care/waitlist control

Sleep quality from questionnaire

 Post-treatment

SMD

2 (35:26)

−0.68 (−2.37, 1.02), p = 0.43

89%

Pain

 Post-treatment only

SMD

2 (35:26)

−0.22 (− 0.93, 0.49), p = 0.54

45%

Group-based exercise versus control

Sleep (various overall measures)

 Post-treatment

SMD

3 (266:240)

−0.10 (− 0.31, 0.12), p = 0.39

27%

Pain

 Post-treatment

SMD

3 (142:125)

−0.52 (− 0.76, − 0.27), p < 0.00001

0%

Anxiety

 Post-treatment

SMD

2 (91:81)

−0.51 (−1.43, 0.40), p = 0.27

86%

Depression

 Post-treatment

SMD

2 (91:81)

−0.41 (−1.26, 0.44), p = 0.35

85%

Tai Ji Quan versus education

Sleep quality from questionnaire

 Post-treatment

MD

2 (45:45)

−0.78 (−2.31, 0.76), p = 0.32

0%

  1. MD Mean difference, SMD Standardised mean difference